A mathematical framework to determine the temporal sequence of somatic genetic events in cancer

被引:89
作者
Attolini, Camille Stephan-Otto [1 ]
Cheng, Yu-Kang [1 ,2 ]
Beroukhim, Rameen [3 ,4 ,5 ,6 ,7 ]
Getz, Gad [3 ]
Abdel-Wahab, Omar [8 ,9 ]
Levine, Ross L. [8 ,9 ]
Mellinghoff, Ingo K. [8 ,10 ]
Michor, Franziska [1 ]
机构
[1] Mem Sloan Kettering Canc Ctr, Computat Biol Ctr, New York, NY 10065 USA
[2] Weill Cornell Med Coll, Tri Inst Training Program Computat Biol & Med, New York, NY 10065 USA
[3] Broad Inst, Canc Program, Cambridge, MA 02142 USA
[4] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA
[5] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA
[6] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA
[7] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA
[8] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10065 USA
[9] Mem Sloan Kettering Canc Ctr, Dept Hematol, New York, NY 10065 USA
[10] Mem Sloan Kettering Canc Ctr, Dept Neurol, New York, NY 10065 USA
基金
美国国家卫生研究院;
关键词
mathematical modeling; stochastic framework; optimization algorithm; GROWTH-FACTOR RECEPTOR; MYELOPROLIFERATIVE DISORDERS; TUMOR-SUPPRESSOR; MYELOID MALIGNANCIES; MUTATIONS; TET2; INACTIVATION; PATHWAYS; TRANSFORMATION; GLIOMAGENESIS;
D O I
10.1073/pnas.1009117107
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Human cancer is caused by the accumulation of genetic alterations in cells. Of special importance are changes that occur early during malignant transformation because they may result in oncogene addiction and represent promising targets for therapeutic intervention. Here we describe a computational approach, called Retracing the Evolutionary Steps in Cancer (RESIC), to deduce the temporal sequence of genetic events during tumorigenesis from cross-sectional genomic data of tumors at their fully transformed stage. When applied to a dataset of 70 advanced colorectal cancers, our algorithm accurately predicts the sequence of APC, KRAS, and TP53 mutations previously defined by analyzing tumors at different stages of colon cancer formation. We further validate the method with glioblastoma and leukemia sample data and then apply it to complex integrated genomics databases, finding that high-level EGFR amplification appears to be a late event in primary glioblastomas. RESIC represents the first evolutionary mathematical approach to identify the temporal sequence of mutations driving tumorigenesis and may be useful to guide the validation of candidate genes emerging from cancer genome surveys.
引用
收藏
页码:17604 / 17609
页数:6
相关论文
共 30 条
[1]   Genetic Analysis of Transforming Events That Convert Chronic Myeloproliferative Neoplasms to Leukemias [J].
Abdel-Wahab, Omar ;
Manshouri, Taghi ;
Patel, Jay ;
Harris, Kelly ;
Yao, JinJuan ;
Hedvat, Cyrus ;
Heguy, Adriana ;
Bueso-Ramos, Carlos ;
Kantarjian, Hagop ;
Levine, Ross L. ;
Verstovsek, Srdan .
CANCER RESEARCH, 2010, 70 (02) :447-452
[2]   Genetic characterization of TET1, TET2, and TET3 alterations in myeloid malignancies [J].
Abdel-Wahab, Omar ;
Mullally, Ann ;
Hedvat, Cyrus ;
Garcia-Manero, Guillermo ;
Patel, Jay ;
Wadleigh, Martha ;
Malinge, Sebastien ;
Yao, JinJuan ;
Kilpivaara, Outi ;
Bhat, Rukhmi ;
Huberman, Kety ;
Thomas, Sabrena ;
Dolgalev, Igor ;
Heguy, Adriana ;
Paietta, Elisabeth ;
Le Beau, Michelle M. ;
Beran, Miloslav ;
Tallman, Martin S. ;
Ebert, Benjamin L. ;
Kantarjian, Hagop M. ;
Stone, Richard M. ;
Gilliland, D. Gary ;
Crispino, John D. ;
Levine, Ross L. .
BLOOD, 2009, 114 (01) :144-147
[3]   Epidermal growth factor receptor and Ink4a/Arf:: Convergent mechanisms governing terminal differentiation and transformation along the neural stem cell to astrocyte axis [J].
Bachoo, RM ;
Maher, EA ;
Ligon, KL ;
Sharpless, NE ;
Chan, SS ;
You, MJJ ;
Tang, Y ;
DeFrances, J ;
Stover, E ;
Weissleder, R ;
Rowitch, DH ;
Louis, DN ;
DePinho, RA .
CANCER CELL, 2002, 1 (03) :269-277
[4]   The COSMIC (Catalogue of Somatic Mutations in Cancer) database and website [J].
Bamford, S ;
Dawson, E ;
Forbes, S ;
Clements, J ;
Pettett, R ;
Dogan, A ;
Flanagan, A ;
Teague, J ;
Futreal, PA ;
Stratton, MR ;
Wooster, R .
BRITISH JOURNAL OF CANCER, 2004, 91 (02) :355-358
[5]   Assessing the significance of chromosomal aberrations in cancer: Methodology and application to glioma [J].
Beroukhim, Rameen ;
Getz, Gad ;
Nghiemphu, Leia ;
Barretina, Jordi ;
Hsueh, Teli ;
Linhart, David ;
Vivanco, Igor ;
Lee, Jeffrey C. ;
Huang, Julie H. ;
Alexander, Sethu ;
Du, Jinyan ;
Kau, Tweeny ;
Thomas, Roman K. ;
Shah, Kinial ;
Soto, Horacio ;
Perner, Sven ;
Prensner, John ;
Debiasi, Ralph M. ;
Demichelis, Francesca ;
Hatton, Charlie ;
Rubin, Mark A. ;
Garraway, Levi A. ;
Nelson, Stan F. ;
Liau, Linda ;
Mischel, Paul S. ;
Cloughesy, Tim F. ;
Meyerson, Matthew ;
Golub, Todd A. ;
Lander, Eric S. ;
Mellinghoff, Ingo K. ;
Sellers, William R. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2007, 104 (50) :20007-20012
[6]   Many faces of Ras activation [J].
Buday, Laszlo ;
Downward, Julian .
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2008, 1786 (02) :178-187
[7]   Mutation of JAK2 in the myeloproliferative disorders:: timing, clonality studies, cytogenetic associations, and role in leukemic transformation [J].
Campbell, Peter J. ;
Baxter, E. Joanna ;
Beer, Philip A. ;
Scott, Linda M. ;
Bench, Anthony J. ;
Huntly, Brian J. P. ;
Erber, Wendy N. ;
Kusec, Rajko ;
Larsen, Thomas Stauffer ;
Giraudier, Stephane ;
Le Bousse-Kerdiles, Marie-Caroline ;
Griesshammer, Martin ;
Reilly, John T. ;
Cheung, Betty Y. ;
Harrison, Claire N. ;
Green, Anthony R. .
BLOOD, 2006, 108 (10) :3548-3555
[8]   Comprehensive genomic characterization defines human glioblastoma genes and core pathways [J].
Chin, L. ;
Meyerson, M. ;
Aldape, K. ;
Bigner, D. ;
Mikkelsen, T. ;
VandenBerg, S. ;
Kahn, A. ;
Penny, R. ;
Ferguson, M. L. ;
Gerhard, D. S. ;
Getz, G. ;
Brennan, C. ;
Taylor, B. S. ;
Winckler, W. ;
Park, P. ;
Ladanyi, M. ;
Hoadley, K. A. ;
Verhaak, R. G. W. ;
Hayes, D. N. ;
Spellman, Paul T. ;
Absher, D. ;
Weir, B. A. ;
Ding, L. ;
Wheeler, D. ;
Lawrence, M. S. ;
Cibulskis, K. ;
Mardis, E. ;
Zhang, Jinghui ;
Wilson, R. K. ;
Donehower, L. ;
Wheeler, D. A. ;
Purdom, E. ;
Wallis, J. ;
Laird, P. W. ;
Herman, J. G. ;
Schuebel, K. E. ;
Weisenberger, D. J. ;
Baylin, S. B. ;
Schultz, N. ;
Yao, Jun ;
Wiedemeyer, R. ;
Weinstein, J. ;
Sander, C. ;
Gibbs, R. A. ;
Gray, J. ;
Kucherlapati, R. ;
Lander, E. S. ;
Myers, R. M. ;
Perou, C. M. ;
McLendon, Roger .
NATURE, 2008, 455 (7216) :1061-1068
[9]   Mutation in TET2 in Myeloid Cancers [J].
Delhommeau, Francois ;
Dupont, Sabrina ;
Della Valle, Veronique ;
James, Chloe ;
Trannoy, Severine ;
Masse, Aline ;
Kosmider, Olivier ;
Le Couedic, Jean-Pierre ;
Robert, Fabienne ;
Alberdi, Antonio ;
Lecluse, Yann ;
Plo, Isabelle ;
Dreyfus, Francois J. ;
Marzac, Christophe ;
Casadevall, Nicole ;
Lacombe, Catherine ;
Romana, Serge P. ;
Dessen, Philippe ;
Soulier, Jean ;
Viguie, Franck ;
Fontenay, Michaela ;
Vainchenker, William ;
Bernard, Olivier A. .
NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (22) :2289-2301
[10]   A GENETIC MODEL FOR COLORECTAL TUMORIGENESIS [J].
FEARON, ER ;
VOGELSTEIN, B .
CELL, 1990, 61 (05) :759-767